| Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome NA Stearns, LR Schaevitz, H Bowling, N Nag, UV Berger, ... Neuroscience 146 (3), 907-921, 2007 | 229 | 2007 |
| Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32 E Valjent, J Bertran-Gonzalez, H Bowling, S Lopez, E Santini, ... Neuropsychopharmacology 36 (12), 2561-2570, 2011 | 80 | 2011 |
| Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity H Bowling, G Zhang, A Bhattacharya, LM Pérez-Cuesta, K Deinhardt, ... Science signaling 7 (308), ra4-ra4, 2014 | 63 | 2014 |
| In-depth quantitative proteomic analysis of de novo protein synthesis induced by brain-derived neurotrophic factor G Zhang, H Bowling, N Hom, K Kirshenbaum, E Klann, MV Chao, ... Journal of proteome research 13 (12), 5707-5714, 2014 | 59 | 2014 |
| BONLAC: A combinatorial proteomic technique to measure stimulus-induced translational profiles in brain slices H Bowling, A Bhattacharya, G Zhang, JZ Lebowitz, D Alam, PT Smith, ... Neuropharmacology 100, 76-89, 2016 | 54 | 2016 |
| Shaping dendritic spines in autism spectrum disorder: mTORC1-dependent macroautophagy H Bowling, E Klann Neuron 83 (5), 994-996, 2014 | 40 | 2014 |
| Altered steady state and activity-dependent de novo protein expression in fragile X syndrome H Bowling, A Bhattacharya, G Zhang, D Alam, JZ Lebowitz, ... Nature communications 10 (1), 1710, 2019 | 29 | 2019 |
| Deconstructing brain-derived neurotrophic factor actions in adult brain circuits to bridge an existing informational gap in neuro-cell biology H Bowling, A Bhattacharya, E Klann, MV Chao Neural regeneration research 11 (3), 363-367, 2016 | 26 | 2016 |
| Unlocking the molecular mechanisms of antipsychotics–a new frontier for discovery H Bowling, E Santini Swiss Medical Weekly 146 (2728), w14314-w14314, 2016 | 14 | 2016 |
| Blood-based biomarkers predictive of metformin target engagement in fragile X syndrome M Jasoliya, H Bowling, IC Petrasic, B Durbin-Johnson, E Klann, ... Brain sciences 10 (6), 361, 2020 | 6 | 2020 |
| Optimization of Protocols for Detection of De Novo Protein Synthesis in Whole Blood Samples via Azide–Alkyne Cycloaddition HL Bowling, A Kasper, C Patole, JP Venkatasubramani, SP Leventer, ... Journal of proteome research 19 (9), 3856-3866, 2020 | 5 | 2020 |
| Interactions between sleep disruption, motor learning, and p70 S6 kinase 1 signaling K Kam, M Kang, CY Eren, WD Pettibone, H Bowling, S Taveras, A Ly, ... Sleep 43 (3), zsz244, 2020 | 5 | 2020 |
| Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11. 2 deletion syndrome M Zafarullah, K Angkustsiri, A Quach, S Yeo, BP Durbin-Johnson, ... Metabolomics 20 (2), 31, 2024 | 2 | 2024 |
| Proteomic approaches to dissect neuronal signalling pathways HL Bowling, S Nayak, K Deinhardt Advancements of Mass Spectrometry in Biomedical Research, 469-475, 2019 | 2 | 2019 |
| Proteomic Tools to Study the Effect of BDNF on De Novo Protein Synthesis H Bowling, E Klann Brain-Derived Neurotrophic Factor (BDNF), 217-239, 2019 | 2 | 2019 |
| Opto4E-BP, an optogenetic tool for inducible, reversible, and cell type-specific inhibition of translation initiation JM Alapin, MS Mohamed, P Shrestha, HG Khaled, AG Vorabyeva, ... bioRxiv, 2023.08. 30.554643, 2023 | 1 | 2023 |
| Proteomic approaches to dissect neuronal signaling pathways HL Bowling, K Deinhardt Advancements of Mass Spectrometry in Biomedical Research, 499-508, 2014 | 1 | 2014 |
| Method for patient stratification and drug efficacy monitoring HL Bowling, A Bhattacharya, E Klann US Patent 10,502,749, 2019 | | 2019 |
| Acknowledgement to Reviewers of Journal of Developmental Biology in 2018 J Ahringer, C Allen, K Artinger, P Askjaer, D Atukorallaya, AA Baburamani, ... | | 2019 |
| Brain-Derived Neurotrophic Factor and the Attività plastica dei neuroni: The Neuronal Plasticity as Defined by Ernesto Lugaro (1870–1940) H Bowling, MV Chao Brain-Derived Neurotrophic Factor (BDNF), 3-10, 2019 | | 2019 |